Ongoing disease activity and changing categories in a long‐term nordic cohort study of juvenile idiopathic arthritis
2011/05/10 by Ellen Nordal, Marek Zak, Marek Žák +10 · 26 citations
Medicine · Health Professions · #Autoimmune and Inflammatory Disorders Research #Adolescent and Pediatric Healthcare #Rheumatoid Arthritis Research and Therapies
paper · doi:10.1002/art.30426
Abstract
OBJECTIVE: To describe the disease characteristics, long-term course, and outcome of patients with juvenile idiopathic arthritis (JIA) in a population-based setting. METHODS: Consecutive cases of JIA from defined geographic areas of Denmark, Finland, Sweden, and Norway in whom disease onset occurred in 1997-2000 were included in a prospective, multicenter cohort study. The study was designed to be as close to a population-based study as possible, with centers participating only if they were able to include in their catchment area all children in whom JIA was diagnosed. RESULTS: Of 500 children included, 440 (88.0%) had repeated visits, with the last visit occurring at least 7 years after disease onset (median 98 months, range 84-147 months). Changes in the International League of Associations for Rheumatology category were observed in 10.8% of the children, and, in addition, extended oligoarthritis developed in 34.7% of the group with oligoarticular JIA. During the observation period, 58.0% of the children were treated with disease-modifying antirheumatic drugs, including biologic medications. Ongoing disease activity was mostly mild, but some JIA-related damage developed in 22.9% of the children. At the last followup visit, remission off medication was observed in 42.4% of the children, 8.9% were in remission on medication, and 48.7% were not in remission. The highest rates of remission were observed in patients with persistent oligoarticular JIA and in those with systemic JIA. CONCLUSION: In this long-term prospective study of JIA in a population-based Nordic setting, ongoing disease was evident in a majority of the children. The present results underline the need to identify early predictors of outcome, to further improve therapy, and to continue long-term followup of patients with JIA.
Citations
Cited by
- Disease progression into adulthood and predictors of long-term active disease in juvenile idiopathic arthritis
- Incidence and prevalence of juvenile idiopathic arthritis among children in a managed care population, 1996-2009. [europepmc]
- Temporomandibular signs, symptoms, joint alterations and disease activity in juvenile idiopathic arthritis - an observational study. [europepmc]
- Complementary and alternative medicine use in adolescents with inflammatory bowel disease and juvenile idiopathic arthritis. [europepmc]
- Genome-wide data reveal novel genes for methotrexate response in a large cohort of juvenile idiopathic arthritis cases. [europepmc]
- Anti-type II collagen antibodies, anti-CCP, IgA RF and IgM RF are associated with joint damage, assessed eight years after onset of juvenile idiopathic arthritis (JIA). [europepmc]
- Juvenile Idiopathic Arthritis in Olmsted County, Minnesota, 1960-2013. [europepmc]
- Reduced physical activity in children and adolescents with Juvenile Idiopathic Arthritis despite satisfactory control of inflammation. [europepmc]
- The majority of newly diagnosed patients with juvenile idiopathic arthritis reach an inactive disease state within the first year of specialised care: data from a German inception cohort. [europepmc]
- Juvenile idiopathic arthritis in adulthood: fulfilment of classification criteria for adult rheumatic diseases, long-term outcomes and predictors of inactive disease, functional status and damage. [europepmc]
- How common is clinically inactive disease in a prospective cohort of patients with juvenile idiopathic arthritis? The importance of definition. [europepmc]
- Course of patients with juvenile spondyloarthritis during 4 years of observation, juvenile part of GESPIC. [europepmc]
- A survey of national and multi-national registries and cohort studies in juvenile idiopathic arthritis: challenges and opportunities. [europepmc]
- Multicenter inception cohort of enthesitis-related arthritis: variation in disease characteristics and treatment approaches. [europepmc]
- Incidence and predictors of Uveitis in juvenile idiopathic arthritis in a Nordic long-term cohort study. [europepmc]
- Review: Genetics and the Classification of Arthritis in Adults and Children. [europepmc]
- Predicting unfavorable long-term outcome in juvenile idiopathic arthritis: results from the Nordic cohort study. [europepmc]
- The majority of patients with newly diagnosed juvenile idiopathic arthritis achieve a health-related quality of life that is similar to that of healthy peers: results of the German multicenter inception cohort (ICON). [europepmc]
- Participation in school and physical education in juvenile idiopathic arthritis in a Nordic long-term cohort study. [europepmc]
- Enthesitis-related arthritis is the most common category of juvenile idiopathic arthritis in Taiwan and presents persistent active disease. [europepmc]
- Outcome in juvenile idiopathic arthritis: a population-based study from Sweden. [europepmc]
- Making Decisions About Stopping Medicines for Well-Controlled Juvenile Idiopathic Arthritis: A Mixed-Methods Study of Patients and Caregivers. [europepmc]
- Long-term outcomes and disease course of children with juvenile idiopathic arthritis in the ReACCh-Out cohort: a two-centre experience. [europepmc]
- Long-term outcomes in patients with polyarticular juvenile idiopathic arthritis receiving adalimumab with or without methotrexate. [europepmc]
- Salivary Oral Microbiome of Children With Juvenile Idiopathic Arthritis: A Norwegian Cross-Sectional Study. [europepmc]
- Fatigue in young adults with juvenile idiopathic arthritis 18 years after disease onset: data from the prospective Nordic JIA cohort. [europepmc]
Related